These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38642509)
21. Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer. Hou Y; Zhang R; Zong J; Wang W; Zhou M; Yan Z; Li T; Gan W; Lv S; Zeng Z; Yang M Front Immunol; 2022; 13():892512. PubMed ID: 35711437 [TBL] [Abstract][Full Text] [Related]
22. A five-immune-related genes-based prognostic signature for colorectal cancer. Zhu L; Wang H; Wang Z Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411 [TBL] [Abstract][Full Text] [Related]
23. Exploring exosome data to identify prognostic gene signatures for lung adenocarcinoma. Li J; Gao X; Tian S; Tang M; Liu W Future Oncol; 2021 Dec; 17(34):4745-4756. PubMed ID: 34658257 [TBL] [Abstract][Full Text] [Related]
24. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer. Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M Front Immunol; 2022; 13():994874. PubMed ID: 36330513 [TBL] [Abstract][Full Text] [Related]
26. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
27. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer. Yang C; Cao F; Huang S; Zheng Y Front Immunol; 2021; 12():717505. PubMed ID: 34335633 [TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients. Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005 [TBL] [Abstract][Full Text] [Related]
29. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer. Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544 [TBL] [Abstract][Full Text] [Related]
30. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of Gene Expression Profiles Identifies a Chen Z; Chen M; Xue Z; Zhu X Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234 [No Abstract] [Full Text] [Related]
32. Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients. Zhu Z; Geng R; Zhang Y; Liu J; Bai J J Immunol Res; 2023; 2023():8727884. PubMed ID: 36726489 [TBL] [Abstract][Full Text] [Related]
33. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related]
34. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients. Qian J; Zeng L; Jiang X; Zhang Z; Luo X Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680 [TBL] [Abstract][Full Text] [Related]
35. Integrated analysis of the functions and clinical implications of exosome circRNAs in colorectal cancer. Lei T; Zhang Y; Wang X; Liu W; Feng W; Song W Front Immunol; 2022; 13():919014. PubMed ID: 35924235 [TBL] [Abstract][Full Text] [Related]
36. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
37. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer. Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma. Bi Y; Wu ZH; Cao F BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019 [TBL] [Abstract][Full Text] [Related]
39. An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients. Shao Y; Jia H; Huang L; Li S; Wang C; Aikemu B; Yang G; Hong H; Yang X; Zhang S; Sun J; Zheng M Front Oncol; 2021; 11():711776. PubMed ID: 34249766 [TBL] [Abstract][Full Text] [Related]
40. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer. Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]